Investee Company Update: Yooma Wellness Inc.

RNS Number : 8067M

Seed Innovations Limited

25 May 2022

 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

25 May 2022

SEED Innovations Limited ('SEED' or the 'Company')

Investee Company Update: Yooma Wellness Inc.

SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, notes that following its suspension of trading announced on 4 May 2022, investee company Yooma Wellness Inc. ('Yooma') has been reinstated for trading on the Canadian Securities Exchange ('CSE'), with immediate effect.

Yooma is a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands. SEED has a holding of 4,427,609 ordinary shares in Yooma representing approximately 4.4% of Yooma's issued share capital.

About Yooma Wellness Inc.

Yooma's mission is to build a vertically-integrated global leader in the manufacturing, marketing, distribution, and sale of wellness products including hemp seed oil and hemp-derived and cannabinoid (CBD) ingredients. The company leverages strategically curated sales channels and ecommerce networks to deliver a diverse mix of wellness products through operating subsidiaries in the United States, United Kingdom, France and Japan. Learn more at   www.yooma.ca

***ENDS***

For further information on the Company please visit   www.seedinnovations.co  or contact:

Ed McDermott Lance de Jersey	SEED Innovations Ltd	E: [e-mail]
James Biddle Roland Cornish	Beaumont   Cornish   Limited, Nomad	T: (0)20 7628 3396
Isabella Pierre Damon Heath	Shard Capital Partners LLP Broker	T: (0)20 7186 9927
Catherine Leftley Isabelle Morris	St Brides Partners Ltd, Financial PR	E: [e-mail]

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

END

 

 

MSCFLFIVEVIEFIF